Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis

被引:139
作者
Kawamura, M
Fijimoto, S
Hisanaga, S
Yamamoto, Y
Eto, T
机构
[1] Miyazaki Med Coll, Dept Internal Med 1, Kiyotake, Miyazaki 88916, Japan
[2] Yamamoto Clin, Miyazaki, Japan
关键词
cerebral hemorrhage; cerebrovascular disease; hemodialysis patients; hypertension;
D O I
10.1053/ajkd.1998.v31.pm9631844
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We retrospectively investigated the incidence and prognosis of and risk factors for cerebrovascular events in 1,064 patients with chronic uremia who received maintenance hemodialysis (HD) for more than 3 months during 24 years in our dialysis units in Miyazaki, Japan. Cerebrovascular events developed in 98 patients (9.2%), The confirmed incidences of cerebral hemorrhage (CH) and infarction were 8.7 and 3.7 per 1,000 patient-years, respectively. Of the 56 patients with CH, 40 (71.4%) died within 3 months of the onset of CH, Ganglio thalamic lesion was observed in 32 (80.0%) of 40 patients with CH confirmed by a brain computed tomography, The incidence of polycystic kidney disease was higher in the CH group than in the overall HD population (12.5% v 3.9%, P < 0.01), Of the 13 patients with diabetes mellitus and nephrosclerosis, nine (69.2%) developed CH within 36 months of the initiation of HD; 11 (78.6%) of 14 patients with chronic glomerulonephritis developed CH after 36 months, CH developed in six patients (15.0%) within 6 hours of a previous HD session, We compared laboratory values, the supine blood pressure, and electrocardiographic (ECG) findings in 35 patients with CH and a control group (66 patients) matched in age, sex, basal renal disease, age at the initiation of HD, and the duration of HD, Data were obtained before and after HD 3 to 4 months before the first attack of CH. The systolic and diastolic blood pressure (SBP, DBP) before and after HD were significantly higher in the CH group than in the control group (pre-HD SEP: 171 +/- 22.5 v 154 +/- 19.3 mm Hg, P < 0.001; pre-HD DBP: 89 +/- 13.6 v 81 +/- 9.6 mm Hg, P < 0.001). The incidence of left ventricular hypertrophy was higher, and the Kt/V was significantly lower (1.23 +/- 0.26 v 1.38 +/- 0.34, P < 0.05) in the CH group than in the control group. However, there were no significant differences in the serum levels of albumin and cholesterol or the total dose of heparin during HD sessions between groups, In conclusion, the incidence of CH was high, and its prognosis was poor, in patients undergoing maintenance HD, Reversible risk factors include hypertension and possibly the amount of HD prescribed, but not anticoagulation with heparin. (C) 1998 by the National Kidney Foundation, Inc.
引用
收藏
页码:991 / 996
页数:6
相关论文
共 28 条
[1]   MARKERS FOR SURVIVAL IN DIALYSIS - A 7-YEAR PROSPECTIVE-STUDY [J].
AVRAM, MM ;
MITTMAN, N ;
BONOMINI, L ;
CHATTOPADHYAY, J ;
FEIN, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :209-219
[2]   Relationship of dose of hemodialysis and cause-specific mortality [J].
Bloembergen, WE ;
Stannard, DC ;
Port, FK ;
Wolfe, RA ;
Pugh, JA ;
Jones, CA ;
Greer, JW ;
Golper, TA ;
Held, PJ .
KIDNEY INTERNATIONAL, 1996, 50 (02) :557-565
[3]   MORTALITY RISK-FACTORS IN PATIENTS TREATED BY CHRONIC-HEMODIALYSIS - REPORT OF THE DIAPHANE COLLABORATIVE STUDY [J].
DEGOULET, P ;
LEGRAIN, M ;
REACH, I ;
AIME, F ;
DEVRIES, C ;
ROJAS, P ;
JACOBS, C .
NEPHRON, 1982, 31 (02) :103-110
[4]   RISK-FACTORS OF STROKE INCIDENCE AND MORTALITY - A 12-YEAR FOLLOW-UP OF THE OSLO STUDY [J].
HAHEIM, LL ;
HOLME, I ;
HJERMANN, I ;
LEREN, P .
STROKE, 1993, 24 (10) :1484-1489
[5]   The dose of hemodialysis and patient mortality [J].
Held, PJ ;
Port, FK ;
Wolfe, RA ;
Stannard, DC ;
Carroll, CE ;
Daugirdas, JT ;
Bloembergen, WE ;
Greer, JW ;
Hakim, RM .
KIDNEY INTERNATIONAL, 1996, 50 (02) :550-556
[6]   PROGNOSIS FOR PATIENTS TREATED CONSERVATIVELY FOR SPONTANEOUS INTRACEREBRAL HEMATOMAS [J].
HELWEGLARSEN, S ;
SOMMER, W ;
STRANGE, P ;
LESTER, J ;
BOYSEN, G .
STROKE, 1984, 15 (06) :1045-1048
[7]   CBF AND OXYGEN-METABOLISM IN HEMODIALYSIS-PATIENTS - EFFECTS OF ANEMIA CORRECTION WITH RECOMBINANT HUMAN EPO [J].
HIRAKATA, H ;
YAO, H ;
OSATO, S ;
IBAYASHI, S ;
ONOYAMA, K ;
OTSUKA, M ;
ICHIYA, Y ;
KUWABARA, Y ;
MASUDA, Y ;
FUJISHIMA, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :F737-F743
[8]   EVIDENCE FOR HIGH-RISK OF CEREBRAL-HEMORRHAGE IN CHRONIC DIALYSIS PATIENTS [J].
ISEKI, K ;
KINJO, K ;
KIMURA, Y ;
OSAWA, A ;
FUKIYAMA, K .
KIDNEY INTERNATIONAL, 1993, 44 (05) :1086-1090
[9]   SURVIVAL ANALYSIS OF DIALYSIS PATIENTS IN OKINAWA, JAPAN (1971-1990) [J].
ISEKI, K ;
KAWAZOE, N ;
OSAWA, A ;
FUKIYAMA, K .
KIDNEY INTERNATIONAL, 1993, 43 (02) :404-409
[10]   SERUM-ALBUMIN IS A STRONG PREDICTOR OF DEATH IN CHRONIC DIALYSIS PATIENTS [J].
ISEKI, K ;
KAWAZOE, N ;
FUKIYAMA, K .
KIDNEY INTERNATIONAL, 1993, 44 (01) :115-119